Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

TEVA – Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries
TEVA
$17.78
Name : Teva Pharmaceutical Industries
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $21,044,940,800.00
EPSttm : -1.15
finviz dynamic chart for TEVA
Teva Pharmaceutical Industries
$17.78
3.13%
$0.54

Float Short %

3.38

Margin Of Safety %

7

Put/Call OI Ratio

0.53

EPS Next Q Diff

0.23

EPS Last/This Y

0.05

EPS This/Next Y

0.22

Price

17.25

Target Price

24.5

Analyst Recom

1.44

Performance Q

12.38

Relative Volume

0.88

Beta

0.61

Ticker: TEVA




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-05-07TEVA17.580.620.391075154
2025-05-08TEVA18.080.630.511081397
2025-05-09TEVA16.940.640.921106005
2025-05-12TEVA17.960.590.731060618
2025-05-13TEVA17.490.580.441023112
2025-05-14TEVA16.890.580.631023864
2025-05-15TEVA16.890.580.271026417
2025-05-16TEVA16.940.620.251056560
2025-05-19TEVA17.010.610.861019110
2025-05-20TEVA16.780.600.551024367
2025-05-21TEVA16.570.600.041026603
2025-05-22TEVA16.930.480.281196451
2025-05-23TEVA16.950.481.041199495
2025-05-27TEVA17.730.490.111196799
2025-05-28TEVA18.150.540.271136137
2025-05-29TEVA17.50.540.231141843
2025-05-30TEVA16.760.541.081155158
2025-06-02TEVA17.270.530.351133355
2025-06-03TEVA17.20.540.791136102
2025-06-04TEVA17.520.542.321137644
2025-06-05TEVA17.250.530.661137592
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-05-07TEVA17.60-3.42244.22.56
2025-05-08TEVA18.08-3.42239.52.56
2025-05-09TEVA16.947.91423.82.53
2025-05-12TEVA17.967.91562.02.53
2025-05-13TEVA17.487.91493.62.53
2025-05-14TEVA16.897.91484.22.53
2025-05-15TEVA16.897.21500.82.53
2025-05-16TEVA16.957.21508.92.55
2025-05-19TEVA17.024.71531.42.55
2025-05-20TEVA16.784.71570.72.55
2025-05-21TEVA16.574.71494.72.55
2025-05-22TEVA16.944.71534.32.55
2025-05-23TEVA16.954.71542.22.55
2025-05-27TEVA17.714.71608.22.55
2025-05-28TEVA18.154.71560.12.55
2025-05-29TEVA17.543.81510.42.55
2025-05-30TEVA16.783.81468.72.55
2025-06-02TEVA17.283.81499.22.55
2025-06-03TEVA17.193.21500.62.54
2025-06-04TEVA17.523.21516.72.54
2025-06-05TEVA17.253.21553.22.54
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-05-07TEVA-81.228.042.65
2025-05-08TEVA-81.228.042.65
2025-05-09TEVA-81.228.042.65
2025-05-12TEVA-85.296.722.48
2025-05-13TEVA-85.296.722.48
2025-05-14TEVA-85.296.722.48
2025-05-15TEVA-31.696.722.49
2025-05-16TEVA-31.696.722.49
2025-05-19TEVA-31.696.832.48
2025-05-20TEVA-92.066.832.48
2025-05-21TEVA-92.066.832.48
2025-05-22TEVA-91.956.832.48
2025-05-23TEVA-91.956.832.48
2025-05-27TEVA-91.956.232.48
2025-05-28TEVA-91.956.233.38
2025-05-29TEVA-91.956.233.38
2025-05-30TEVA-91.956.233.38
2025-06-02TEVA-91.956.073.38
2025-06-03TEVA-91.956.073.38
2025-06-04TEVA-91.956.073.38
2025-06-05TEVA-91.996.073.38
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.49

Avg. EPS Est. Current Quarter

0.63

Avg. EPS Est. Next Quarter

0.72

Insider Transactions

-91.99

Institutional Transactions

6.07

Beta

0.61

Average Sales Estimate Current Quarter

4337

Average Sales Estimate Next Quarter

4464

Fair Value

18.47

Quality Score

47

Growth Score

51

Sentiment Score

15

Actual DrawDown %

24.3

Max Drawdown 5-Year %

-47.3

Target Price

24.5

P/E

Forward P/E

6.31

PEG

P/S

1.19

P/B

3.16

P/Free Cash Flow

9.49

EPS

-1.14

Average EPS Est. Cur. Y​

2.54

EPS Next Y. (Est.)

2.76

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-7.76

Relative Volume

0.88

Return on Equity vs Sector %

-44.5

Return on Equity vs Industry %

-28.4

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

1553.2
Teva Pharmaceutical Industries
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 37000
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO to treat neurodegenerative and movement disorders – chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.
stock quote shares TEVA – Teva Pharmaceutical Industries Limited Stock Price stock today
news today TEVA – Teva Pharmaceutical Industries Limited stock forecast ,stock prediction 2023 2024 2025
marketwatch TEVA – Teva Pharmaceutical Industries Limited yahoo finance google finance
stock history TEVA – Teva Pharmaceutical Industries Limited invest stock market
stock prices TEVA premarket after hours
ticker TEVA fair value insiders trading